Cipher Pharmaceuticals and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of Epuris®
Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba